| Alexion Pharmaceuticals INC ALEXION PHARMACEUTICALS ORD SHS | 156.43 |
| Date/Time | 01/12 / 19:17 |
| Chg. / Chg.(%) | - / |
| Bid | - |
| Ask | 129.00 / 6000 |
| Open | 156.43 |
| Previous Close | 157.07 |
| High | 156.43 |
| Low | 156.43 |
| Volume [USD] | 2,346,495.00 |
| Volume [Units] | 30,004 |
| Price fixings | 3 |
| ISIN | US0153511094 |
| Security | 0QZM |
| Exchange | London International |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| NASDAQ | 156.7000 |  |
2,106,122 |
| Cboe US | 156.73 | |
134,123 |
| IEX | 156.72 | |
77,464 |
| Frankfurt | 128.1400 | |
30 |
| TradeGate | 129.620 | |
22 |
| Xetra | 129.94 | |
11 |
| Stuttgart | 129.460 | |
1 |
| Düsseldorf | 129.76 | |
0 |
| Berlin | 128.32 | |
0 |
| München | 128.38 | |
0 |
| Vienna Globa.. | 129.78 | |
0 |
| gettex | 129.700 | |
|
| Lang & Schwa.. | 128.00 | |
|
| London Inter.. | 156.43 | 30,004 | |
| Mexico | 3,120.34 |  |
640 |
News
- BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
01/15/2021 / 14:30 - GlobeNewswire - Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
01/15/2021 / 14:00 - GlobeNewswire - Salarius Pharmaceuticals Announces Dr. Daniela Santiesteban to Participate in Panel Discussion on Targeted Cancer Therapies During Virtual NobleCon17 Investor Conference
01/15/2021 / 13:30 - GlobeNewswire - InvestorBrandNetwork Announces C3 Chat Show Podcast with CNS Pharmaceuticals Inc. Chairman and CEO John Climaco
01/13/2021 / 14:30 - GlobeNewswire - Processa Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
01/11/2021 / 16:50 - GlobeNewswire
Real-time